timate the prevalence of diabetes, the percentage of those who were unaware of their diabetes, and the prediabetes prevalence among adolescents using nationally representative data.
Methods | The National Health and Nutrition Examination Survey (NHANES) is a series of 2-year stratified, multistage probability surveys representative of the civilian, noninstitutionalized US population, which include in-person interviews and examinations in mobile centers. 3 We used data from [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] (in which all relevant glucose data were available) from adolescents aged 12 to 19 years who were randomly selected for the morning examination session after fasting. The response rate among adolescents was 83% for the interview and 81% for the examination. Written informed consent was obtained from participants aged 18 to 19 years; among participants aged 12 to 17 years, written assent was obtained and written informed consent from parents/guardians. The research ethics boards of the National Center for Health Statistics approved all protocols. A questionnaire was used to collect demographic information.
3 Participants were asked if they had ever been diagnosed with diabetes by a "doctor or other health professional." Hemoglobin A 1c and fasting plasma glucose (FPG) were measured and FPG was calibrated over time. 3 An oral glucose tolerance test was administered using 75 g of glucose, followed by venipuncture to measure 2-hour plasma glucose (2HPG). Diabetes was defined as a previous diagnosis, a hemoglobin A 1c level of 6.5% or more, an FPG level of 126 mg/dL or more, or a 2HPG level of 200 mg/dL or more (to convert glucose to mmol/L, multiply by 0.0555). Prediabetes was defined as not having diabetes and having a hemoglobin A 1c level of 5.7% to 6.4%, an FPG level of 100 mg/dL to 125 mg/dL, or a 2HPG level of 140 mg/dL to 199 mg/dL. The diabetes prevalence, the percentage that was undiagnosed (ie, unaware of their condition), and the prediabetes prevalence overall and stratified by sex and race/ethnicity were calculated. A regression model with diabetes as the outcome and time as the predictor was used to assess trends over time. Two-sided P values less than .05 were considered statistically significant.
Sample weights accounting for unequal selection probabilities and nonresponse produced results representative of the total civilian noninstitutionalized US population. 4 Data were analyzed using SUDAAN (RTI International), version 10.0.1.
Results | Of 2606 adolescents included, 62 had diabetes, 20 were undiagnosed, and 512 had prediabetes. The weighted prevalence of diabetes was 0.8% (95% CI, 0.6%-1.1%), of which 28.5% (95% CI, 16.4%-44.8%) was undiagnosed, and the prevalence of prediabetes was 17.7% (95% CI, 15.8%-19.8%) (Table) Discussion | To our knowledge, these are the first estimates of diabetes in a nationally representative sample of US adolescents using all 3 American Diabetes Association (ADA) recommended biomarkers (hemoglobin A 1c , FPG, and 2HPG).
1,2
The estimates are higher than previously reported; 1 study found diagnosed diabetes in 0.34% of participants aged 10 to 19 years.
1 A relatively large proportion was unaware of the condition, particularly among non-Hispanic black participants and Hispanic participants, indicating a need for improved diabetes screening among adolescents. These findings may have important public health implications because diabetes in youth is associated with early onset of risk factors and complications. 5, 6 Study limitations include ascertaining previous diagnosis by self-report. The ADA recommends a repeat measurement after a single positive test using hemoglobin A 1c , FPG, or 2HPG, but NHANES does not repeat such measurements. These issues may result in an overestimation of diabetes prevalence. We could not distinguish type of diabetes, but previous research in adolescents found 87% had type 1.
1 NHANES has unique strengths including a nationally representative sample and the ability to estimate undiagnosed diabetes. 
COMMENT & RESPONSE Outcome After Admission at Veterans Affairs vs Non-Veterans Affairs Hospitals
To the Editor Mr Nuti and colleagues reported that hospitalization at Veterans Affairs (VA) hospitals, compared with non-VA hospitals, was associated with lower 30-day allcause mortality for older men with acute myocardial infarction or heart failure, but higher 30-day readmission rates for acute myocardial infarction, heart failure, or pneumonia. 1 Our question focuses on the study's method of risk adjustmentspecifically, whether the authors' method fully accounts for the burden of comorbid illness among veterans admitted to VA hospitals. It is unclear whether the authors incorporated both VA and Medicare claims, or Medicare claims alone, to identify comorbid conditions for veterans in their riskadjustment models. For VA beneficiaries who are dually enrolled in Medicare, comorbidity codes should be identified from both VA and Medicare claims to accurately capture comorbid conditions. 2,3 Using only Medicare claims to risk adjust would capture a fraction of conditions, thus skewing the results in favor of hospitalization outside the VA (ie, giving the appearance that VA hospitalizations involve patients with less severe comorbid disease). Moreover, if the study only included comorbidities coded within Medicare, this would systematically exclude conditions that are predominantly treated within the VA and have an important effect on mortality and readmission, such as mental illness and substance abuse.
4
Risk adjustment using diagnoses documented in both the VA and Medicare would be an improvement over using codes from only one system. However, the issue of systemic undercoding of conditions within the VA compared with Medicare 
